Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Cystectomy Outcomes
Cystectomy ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s cystectomy ACS NSQIP performance benchmarked against 108 participating sites.
| Cystectomy (108 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 144 | 20.83% | 21.90% |
| Pneumonia | 143 | 1.40% | 1.60% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 144 | 4.17% | 3.06% |
| Renal Failure | 144 | 10.42% | 5.45% |
| Urinary Tract Infection (UTI) | 144 | 0.69% | 3.66% |
| Surgical Site Infection (SSI) | 142 | 6.34% | 10.34% |
| Sepsis | 141 | 6.38% | 9.43% |
| Unplanned Reoperation | 144 | 2.08% | 4.98% |
| Length of Stay | 111 | 13.51% | 15.90% |
| Anastomotic Leak | 144 | 0.69% | 1.40% |
| Rectal Injury | 144 | 0.00% | 1.55% |
| Prolonged NPO/NGT Use | 144 | 13.19% | 19.32% |
| Ureteral Obstruction | 144 | 0.00% | 1.59% |
| Lymphocele/Leak/Fluid | 144 | 0.00% | 2.65% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
